Isabel Kalofonos

Isabel Kalofonos is an accomplished executive in the pharmaceutical and biotechnology industries, currently serving as the Chief Commercial Officer at Crinetics Pharmaceuticals. Prior to this role, Isabel held the position of Chief Commercial Officer at Fulcrum Therapeutics and ImmunoGen, Inc. Additionally, Isabel was the Head of the Prescription Business Unit at Galderma and served as Vice-President of the Genetics Franchise at Shire, where involvement included leading the global launch strategy for TAKHZYRO.